SymBio Pharmaceuticals Limited (TYO:4582)
Japan · Delayed Price · Currency is JPY 119.00
+5.00 (4.39%)
Mar 27, 2026, 3:30 PM JST
SymBio Pharmaceuticals Market Cap
SymBio Pharmaceuticals has a market cap or net worth of 7.61 billion as of March 27, 2026. Its market cap has decreased by -7.28% in one year.
Market Cap
7.61B
Enterprise Value
6.71B
Revenue
1.31B
Ranking
n/a
PE Ratio
n/a
Stock Price
119.00
Market Cap Chart
Since October 20, 2011, SymBio Pharmaceuticals's market cap has increased from 7.08B to 7.61B, an increase of 7.57%. That is a compound annual growth rate of 0.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 7.61B | 51.57% |
| Dec 30, 2025 | 5.02B | -44.92% |
| Dec 30, 2024 | 9.12B | -12.48% |
| Dec 29, 2023 | 10.42B | -58.97% |
| Dec 30, 2022 | 25.40B | -42.20% |
| Dec 30, 2021 | 43.94B | 203.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fuso Pharmaceutical Industries,Ltd. | 20.70B |
| Pharma Foods International | 19.84B |
| Taiko Pharmaceutical | 15.18B |
| Wakamoto Pharmaceutical | 12.66B |
| Morishita Jintan | 9.60B |
| Solasia Pharma K.K. | 8.89B |
| MedRx | 6.95B |
| WDB coco | 6.42B |